Kratz Felix 4
4 · CYTRX CORP · Filed Jan 2, 2018
Insider Transaction Report
Form 4
CYTRX CORPCYTR
Kratz Felix
Vice President Drug Discovery
Transactions
- Award
Stock Option (right to buy)
2017-12-15+25,000→ 25,000 totalExercise: $1.75Exp: 2027-12-14→ CytRx Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This grant constitutes the annual award of stock options to current employees.The stock option vests in equal installments every other month for 24 months, beginning February 15, 2018, provided Reporting Person remains in continuous employ of Issuer, or the conditions for immediate vesting occur.